M. Kathleen Behrens
Chairman
Sarepta Therapeutics, Inc. (SRPT)Equibles does not estimate personal net worth.
Get an email with a short summary when Sarepta Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get SRPT alertsAbout M. Kathleen Behrens
M. Kathleen Behrens is recorded as Chairman at Sarepta Therapeutics, Inc. (SRPT) since January 1, 2009. The newest filing on record that lists M. Kathleen Behrens as Chairman at Sarepta Therapeutics, Inc. (SRPT) is dated April 24, 2026. M. Kathleen Behrens was last confirmed as Board Member at Mimedx Group, Inc. (MDXG) in a filing dated April 30, 2025. Sarepta Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Sarepta Therapeutics, Inc. includes Douglas Ingram (CEO and Board Member), Michael Severino, M.D. (CEO and Board Member), Ryan H. Wong (CFO) and 7 others.
Affiliation history
-
Current
2009-01-01–present
Last confirmed April 24, 2026
-
2019-01-01–2025-04-30
Last confirmed by a filing; no departure on record
Company network
MDXG
Biotechnology · Healthcare
Board Member
Since 2019-01-01, last confirmed 2025-04-30
Leadership on record at Sarepta Therapeutics, Inc.
- Douglas Ingram CEO, Board Member
- Michael Severino, M.D. CEO, Board Member
- Ryan H. Wong CFO
- Ian Estepan COO, Chief Accounting Officer
- Ian M. Estepan COO
- Cristin L. Rothfuss General Counsel
- Claude Nicaise Board Member
- Claude Nicaise, M.D. Board Member
- Deirdre Connelly Board Member
- Douglas S. Ingram Board Member
Recent activity
No call appearances or filed executive changes recorded yet.